Advances in Oculoplastic Surgery: From Eyelid Reconstruction to Innovative Techniques

Editor


E-Mail Website
Guest Editor
2nd Department of Ophthalmology, Aristotle University of Thessaloniki, Papageorgiou General Hospital, GR-56429 Thessaloniki, Greece
Interests: corneal transplantations; anterior segment surgery; cataract surgery; intraoperative floppy iris syndrome; oculoplastic surgery; cornea; eyelid
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Oculoplastic surgery has evolved significantly over recent decades, integrating advances in reconstructive techniques, biomaterials, and aesthetic principles to improve both functional outcomes and patient satisfaction. From complex eyelid reconstruction following trauma or tumor excision to the adoption of minimally invasive procedures and novel technologies, these contributions showcase the breadth of innovation in oculoplastics. This Special Issue brings together original research and clinical reviews that highlight the expanding frontiers of the field, from functional and aesthetic eyelid reconstruction to novel minimally invasive and image-guided approaches. Particular emphasis is placed on techniques that enhance patient outcomes, reduce recovery time, and address complex pathologies with precision. I strongly believe this collection will serve as a valuable resource for clinicians, researchers, and trainees seeking to stay at the forefront of oculoplastic surgery and that it will inspire further innovation and excellence in clinical practice.

You may choose our Joint Special Issue in JCM.

Dr. Argyrios Tzamalis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical & Translational Ophthalmology is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oculoplastic surgery
  • eyelid reconstruction
  • orbital surgery
  • novel minimally invasive
  • image guided

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 10285 KB  
Review
Strategies for Conformer and Prosthetic Therapy in Children with Acquired Eye Loss and Congenital Microphthalmia or Anophthalmia
by Vita Louisa Sophie Dingerkus, Kathleeya Nan Stang-Veldhouse, Brian Sloan and Keith Raymond Pine
J. Clin. Transl. Ophthalmol. 2026, 4(2), 12; https://doi.org/10.3390/jcto4020012 - 28 Apr 2026
Viewed by 831
Abstract
Early eye loss, congenital microphthalmia, and anophthalmia can significantly disrupt facial and psychological development in children. Timely intervention with conformers and ocular prostheses is essential for stimulating orbital growth and supporting healthy psychosocial development. This review presents evidence-based guidelines for ocularists, physicians, and [...] Read more.
Early eye loss, congenital microphthalmia, and anophthalmia can significantly disrupt facial and psychological development in children. Timely intervention with conformers and ocular prostheses is essential for stimulating orbital growth and supporting healthy psychosocial development. This review presents evidence-based guidelines for ocularists, physicians, and allied professionals on fitting conformers and prostheses in young children, emphasizing the need for individualized treatment based on anatomical severity and age. Recommendations include initial conformer fitting within the first month of life for congenital cases or 4–6 weeks post-surgery in acquired cases, with frequent early replacements. For microphthalmia, moderate-to-severe cases require treatment similar to congenital anophthalmia cases; mild-to-moderate cases treatment within months; and mild cases are usually managed individually without urgency. A cosmetic prosthesis is advised the latest after the first year, as growth slows and self-awareness develops. Regular follow-up and adjustments support functional and psychosocial outcomes. We advocate for standardized care protocols to ensure equitable access and consistent long-term results across healthcare systems. Full article
Show Figures

Figure 1

Back to TopTop